Founded in 1975, the Israel Cancer Research Fund (ICRF) is a nonprofit organization dedicated to supporting innovative cancer research conducted by Israeli scientists. To date, ICRF has awarded more than $100 million in funding for nearly 3,000 grants to researchers across Israel's leading institutions. ICRF-funded scientists have been instrumental in the development of breakthrough FDA-approved drugs and continue to make significant contributions in areas such as nano-medicine, immunotherapy, stem cell research, and targeted therapies.